The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations

By  

Current Drug Delivery, Vol. 2, Iss. 4, 2005-10 ,pp. : 341-351

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicogenomics of Cationic Lipid-based Vectors for Gene Therapy: Impact of Microarray Technology

By  

Current Drug Delivery, Vol. 2, Iss. 4, 2005-10 ,pp. : 429-441

Bentham Science Publishers

Access to resources Recommend Favorite

Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs

By Khoo Shui-Mei   Shackleford David M.   Porter Christopher J. H.   Edwards Glenn A.   Charman William N.  

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1460-1465

Springer Publishing Company

Access to resources Recommend Favorite

Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

By Risovic Verica   Rosland Mike   Sivak Olena   Wasan Kishor M.   Bartlett Karen  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 7, 2007-07 ,pp. : 703-707

Informa Healthcare

Access to resources Recommend Favorite

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

By Fukui H.   Koike T.   Nakagawa T.   Saheki A.   Sonoke S.   Tomii Y.   Seki J.  

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite